We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > cancer

News List

BMS’ Opdivo shown to improve five-year lung cancer survival pharmatimes
April 07, 2017
Bristol-Myers Squibb has unveiled “unprecedented” long-term survival data for its cancer immunotherapy Opdivo, showing ...
Cancer Research UK to support Precision Panc project for pancreatic cancer pharmaceutical-technology
March 27, 2017
Cancer Research UK has announced an investment of £10m to support the Precision Panc project, which aims to develop personalised treatments for pancreatic cancer patients.
UK NICE to deny NHS access to BMS’s blood cancer drug Opdivo pharmaceutical-technology
March 17, 2017
The UK’s National Institute for Health and Care Excellence (NICE) has issued a draft guidance that could deny access...
Cancer Research UK, CRT and MRC to target cancer immunotherapies pharmaceutical-technology
January 19, 2017
Cancer Research UK, Cancer Research Technology (CRT) and MRC Technology are set to collaborate in a bid to focus on cancer immunotherapies.

Previous page 1 2 3 4 Next page